Guideline Recommendations for Small Gallbladder Stones

1. Asymptomatic Small Gallbladder Stones

Expectant (watchful‑waiting) management is recommended for patients with asymptomatic small gallbladder stones, irrespective of age or sex, because the benefits of intervention do not outweigh its risks and costs. 1
Prophylactic cholecystectomy should be considered only in high‑risk populations for gallbladder cancer, such as those with a calcified (“porcelain”) gallbladder, Native American (e.g., Pima) ancestry, or stones larger than 3 cm. 1
The baseline annual risk of gallbladder cancer in these patients is low (≈0.02 % per year), translating to an estimated 0.4 % mortality risk over 20 years; however, it remains uncertain whether cholecystectomy actually prevents cancer. 1

Diagnosis of symptomatic gallstones should be confirmed with transabdominal ultrasound and liver‑function testing. 2

When a patient presents with a first episode of biliary‑type pain, clinicians should clarify goals:
- If the primary goal is to prevent recurrent pain, laparoscopic cholecystectomy is recommended.
- If the goal is solely to avoid mortality after a single episode, observation can be considered, as approximately 30 % of patients with one pain episode never experience another. 1

Laparoscopic cholecystectomy is the definitive treatment for symptomatic small gallbladder stones and should be offered to all patients with biliary pain. [2][3]

Pre‑operative endoscopic retrograde cholangiopancreatography (ERCP) with sphincterotomy is advised for patients with confirmed or high‑probability common bile duct stones. 2
Laparoscopic bile‑duct exploration (LBDE) provides effectiveness comparable to ERCP (no difference in mortality or morbidity) while achieving shorter hospital stays, and may be used as an alternative intra‑operative strategy. [2][3]

Leaving the gallbladder in situ after endoscopic clearance of bile‑duct stones markedly increases the risk of recurrent biliary events, including cholangitis; therefore, completion cholecystectomy is advised. 4
In symptomatic patients, prophylactic cholecystectomy reduces mortality compared with watchful waiting (7.9 % vs 14.1 %; relative risk ≈ 1.78), even among high‑risk surgical candidates. 4

Oral ursodeoxycholic acid dissolution therapy is generally not recommended for small gallbladder stones; when used, it requires several months of treatment and is associated with a recurrence rate of up to 50 % within five years among those who achieve initial dissolution. 4